Bio-Reference Laboratories, Inc. (BRLI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
Bio-Reference Laboratories, Inc. (BRLI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					               Bio-Reference Laboratories, Inc. (BRLI) - Pharmaceuticals & Healthcare -
                                    Deals and Alliances Profile
       Reference Code: GDPH224D                                                                                                              Publication Date: JUN 2013

      Company Overview                                                                                            Key Facts
      Bio-Reference Laboratories, Inc. (Bio-Reference) is a regional clinical laboratory that
                                                                                                                  Bio-Reference Laboratories, Inc., Pharmaceuticals
      serves the greater New York metropolitan area. It offers a comprehensive range of
                                                                                                                  & Healthcare, Key Facts, 2012
      laboratory testing services used by healthcare providers in the detection, diagnosis,
      evaluation, monitoring and treatment of diseases. The company has a network of                               Web Address                  www.bioreference.com
      about116 patient service centers in the Northeast for collection of patient specimens.
                                                                                                                   Revenue (US$ million)                            661.66
      Its customer base includes physicians, geneticists, hospitals, clinics, correctional
      and other health facilities. The company, apart from clinical testing operations,                            Number of Employees                               2,726
      provides clinical knowledge management service through its PSIMedica business                                GlobalData
      unit.

      Financial Deals Landscape
        Bio-Reference Laboratories, Inc., Pharmaceuticals & Healthcare,                    Bio-Reference Laboratories, Inc., Pharmaceuticals &
        Deals by Type, 2007 to YTD 2013                                                    Healthcare, Deals By Year, 2007 to YTD 2013


                                                                                                                                         1
                                                                                                              1


                                                                                               No. of Deals



                                                                                                                     0     0      0             0      0      0
                                                                                                              0
                                                                                                                   2007   2008   2009   2010   2011   2012   YTD
                                                                                                                                                             2013


                                                                                           Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                           from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Bio-Reference Laboratories, Inc., Pharmaceuticals &
         Healthcare, Deals By Region, 2007 to YTD 2013
          No. of Deals




                         1
                               1




                                        0         0        0         0
                         0
                             North    Asia-     Europe   Middle   South
                             Americ   Pacific             East     and
                               a                          and     Central
                                                         Africa   Americ
                                                                    a



         Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData


        Bio-Reference Laboratories, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013
        Year                                                                    No. of Deals                                       Deal Value (US$ million)
        2007                                                                                                        NA                                               NA
        2008                                                                                                        NA                                                NA
        2009                                                                                                        NA                                                NA
        2010                                                                                                         1                                                NA
        2011                                                                                                        NA                                                NA
        2012                                                                                                        NA                                                NA
        YTD 2013                                                                                                    NA                                                NA
        Note: Deals include all announced pharmaceuticals & healthcare deals from 2006 onwards, deal values included wherever disclosed, GlobalData



Bio-Reference Laboratories, Inc. - Pharmaceuticals & Healthcare -                                                                                   Reference Code: GDPH224D
Deals and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                   Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Bio-Reference Laboratories, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 .............................................. 4
       Bio-Reference Laboratories, Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013............................................... 5
       Bio-Reference Laboratories, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 .......................................... 6
       Bio-Reference Laboratories, Inc., Medical Devices Deals, 2007 to YTD 2013 ................................................................................... 7
       Bio-Reference Laboratories, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ........................................... 8
       Bio-Reference Laboratories, Inc., Pharmaceuticals & Healthcare, Deal Details................................................................................. 9
          Venture Financing........................................................................................................................................................................... 9
             InCellDx Raises US$4 Million In Venture Financing .................................................................................................................... 9
          Partnerships.................................................................................................................................................................................. 10
             Bio-Reference Labs Enters Into Co-Marketing Agreement With Natera For NIPD Test............................................................ 10
             Bio-Reference Labs Enters Into Collaboration With Massachusetts General Hospital.............................................................. 11
             Practice Fusion Enters Into Agreement With Bio-Reference Labs ............................................................................................ 12
       Bio-Reference Laboratories, Inc. - Key Competitors ........................................................................................................................ 13
       Key Employees ................................................................................................................................................................................ 14
       Locations And Subsidiaries .............................................................................................................................................................. 15
          Head Office ................................................................................................................................................................................... 15
          Other Locations & Subsidiaries ..................................................................................................................................................... 15
       Appendix .......................................................................................................................................................................................... 16
          Methodology ................................................................................................................................................................................. 16
          About GlobalData ......................................................................................................................................................................... 16
          Contact Us .......................
				
DOCUMENT INFO
Description: Bio-Reference Laboratories, Inc. (Bio-Reference) is a regional clinical laboratory that serves the greater New York metropolitan area. It offers a comprehensive range of laboratory testing services used by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company has a network of about116 patient service centers in the Northeast for collection of patient specimens. Its customer base includes physicians, geneticists, hospitals, clinics, correctional and other health facilities. The company, apart from clinical testing operations, provides clinical knowledge management service through its PSIMedica business unit. Bio-Reference conducts its business in New York, New Jersey, Maryland and some parts of Pennsylvania, Delaware and Connecticut. The company is headquartered in Elmwood Park, New Jersey, the US. The company seeks to provide value-added analytics in conjunction with laboratory results. It capitalizes on the clinical market, lead in providing medical information, and pursue strategic growth opportunities through development of new testing services and acquisitions. Bio-Reference Laboratories, Inc. (BRLI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offeri
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.